# Allogene Therapeutics, Inc.: Form 8-K, filed Feb 16, 2024

- Company: [Allogene Therapeutics, Inc.](/companies/allo.md) (CIK 1737287)
- Form: 8-K
- Filed: 2024-02-16
- Accepted by EDGAR: Feb 16, 2024, 08:30 ET
- Period: 2024-02-14
- Accession: 0001193125-24-038107
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1737287/000119312524038107/d754358d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737287/000119312524038107/

## Items reported

- Item 4.02: Non-reliance on financial statements

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737287/000119312524038107/d754358d8k.htm

Filed Feb 16, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-038107. Last ingested by Listed: Nov 10, 2026, 16:34 ET. No prices; not investment advice.
